A. Chang et al., NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions, J NEUROSC, 20(17), 2000, pp. 6404-6412
Multiple sclerosis (MS) is characterized by multifocal loss of myelin, olig
odendrocytes, and axons. Potential MS therapies include enhancement of remy
elination by transplantation or manipulation of endogenous oligodendrocyte
progenitor cells. Characteristics of endogenous oligodendrocyte progenitors
in normal human brain and in MS lesions have not been studied extensively.
This report describes the distribution of cells in sections from normal ad
ult human brain and MS lesions by using antibodies directed against NG2, an
integral membrane chondroitin sulfate proteoglycan expressed by oligodendr
ocyte progenitor cells. Stellate-shaped NG2-positive cells were detected in
the white and gray matter of normal adult human brain and appeared as abun
dant as, but distinct from, astrocytes, oligodendrocytes, and microglia. St
ellate-shaped or elongated NG2-positive cells also were detected in chronic
MS lesions. A subpopulation of the elongated NG2-positive cells expressed
the putative apoptotic signaling molecule p75(NTR). TUNEL-positive cells in
three active, nine chronic active, and four chronic inactive lesions, howe
ver, were p75(NTR)-negative. These studies identify cells with phenotypic m
arkers of endogenous oligodendrocyte progenitors in the mature human CNS an
d suggest that functional subpopulations of NG2-positive cells exist in MS
lesions. Endogenous oligodendrocyte progenitor cells may represent a viable
target for future therapies intended to enhance remyelination in MS patien
ts.